Discover Opportunities months before the RFP drops
Learn more →Retrieving contract details... Hang tight!
See what competitors charge and their contract structure
Spot renewal opportunities 6-12 months before expiration
Analyze buyer's purchasing history and vendor preferences
Track expiration dates across all your target accounts
Reach decision-makers before renewal with competitive intel
Our customers win 3x more contract renewals and replacements
Verified decision-maker contacts
Winning vendor information
Budget & renewal data
Clean & enrich your CRM automatically
Track contract spending & renewal dates
Analyze historical pricing trends
Identify upcoming opportunities
Get complete source documentation & analysis
U.S. Army Medical Research Acquisition Activity (USAMRAA)
This contract includes 1 purchase order from Feb 7, 2022 to Feb 7, 2022
| Buyer | Vendor | Issued Date | Quantity |
|---|---|---|---|
| U.S. Army Medical Research Acquisition Activity (USAMRAA) | Zymeron Corporation | Feb 7, 2022 | 1 |
Full Purchase Intelligence Available
Get complete pricing, descriptions, and financial details for all 1 purchase orders
Unlock Full Details →See what competitors charge and their contract structure
Spot renewal opportunities 6-12 months before expiration
Analyze buyer's purchasing history and vendor preferences
Track expiration dates across all your target accounts
Reach decision-makers before renewal with competitive intel
Our customers win 3x more contract renewals and replacements
No public files available for this contract.
Contract documentation may be available through official government sources or agency portals. Starbridge can help you track down and retrieve these files.
U.S. Army Medical Research Acquisition Activity (USAMRAA)
DHA SBIR DIRECT TO PH II MEDICAL R&D CONTRACT AWARDED FROM PROPOSAL NO.-H2D-0119 FOR "DEVELOPMENT FOR SHOCKDEFENDER AGAINST HEMORRHAGIC SHOCK"
Effective Date
Sep 15, 2023
Expires
Effective: Sep 15, 2023
U.S. Army Medical Research Acquisition Activity (USAMRAA)
Expires:
DHA SBIR DIRECT TO PH II MEDICAL R&D CONTRACT AWARDED FROM PROPOSAL NO.-H2D-0119 FOR "DEVELOPMENT FOR SHOCKDEFENDER AGAINST HEMORRHAGIC SHOCK"
ActiveU.S. Army Medical Research Acquisition Activity (USAMRAA)
DHA SBIR DIRECT PHASE II H2D-0243 RAPID SAMPLE PROCESSING DEVICE TO SUPPORT BATTLEFIELD WOUND INFECTION DIAGNOSTICS
Effective Date
Sep 20, 2024
Expires
Effective: Sep 20, 2024
U.S. Army Medical Research Acquisition Activity (USAMRAA)
Expires:
DHA SBIR DIRECT PHASE II H2D-0243 RAPID SAMPLE PROCESSING DEVICE TO SUPPORT BATTLEFIELD WOUND INFECTION DIAGNOSTICS
ActiveU.S. Army Medical Research Acquisition Activity (USAMRAA)
DHA STTR PH II MEDICAL RESEARCH AND DEVELOPMENT CONTRACT FOR PROJECT TITLED, "COMPACT LITTER ASSIST FOR WARFIGHTERS"
Effective Date
Feb 5, 2025
Expires
Effective: Feb 5, 2025
U.S. Army Medical Research Acquisition Activity (USAMRAA)
Expires:
DHA STTR PH II MEDICAL RESEARCH AND DEVELOPMENT CONTRACT FOR PROJECT TITLED, "COMPACT LITTER ASSIST FOR WARFIGHTERS"
ActiveU.S. Army Medical Research Acquisition Activity (USAMRAA)
SCIENTIFIC SUPPORT SERIVCES PHILIPPINES, NEPAL AND CAMBODIA IN SUPPORT OF UNITED STATES ARMY MEDICAL DIRECTORATE - ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES
Effective Date
Dec 21, 2023
Expires
Effective: Dec 21, 2023
U.S. Army Medical Research Acquisition Activity (USAMRAA)
Expires:
SCIENTIFIC SUPPORT SERIVCES PHILIPPINES, NEPAL AND CAMBODIA IN SUPPORT OF UNITED STATES ARMY MEDICAL DIRECTORATE - ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES
ActiveSee who's winning contracts, track spending trends, and identify your best opportunities before your competition.
Schedule Your Demo →Verified decision-maker contacts
Winning vendor information
Budget & renewal data
Clean & enrich your CRM automatically
Track contract spending & renewal dates
Analyze historical pricing trends
Identify upcoming opportunities
Get complete source documentation & analysis